HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

alpha-keto-delta-Guanidinovaleric acid

HCID 558
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
3715-10-4
Standard SMILES
NC(N)=NCCCC(=O)C(=O)O
InChIKey
ARBHXJXXVVHMET-UHFFFAOYSA-N
Molecular formula
C6H11N3O3
Average molar mass
173.17 g/mol
Monoisotopic mass
173.08004122

Overview

5-guanidino-2-oxopentanoic acid is a 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group. It has a role as a mouse metabolite and a human metabolite. It is functionally related to a valeric acid. It is a conjugate acid of a 5-guanidino-2-oxopentanoate. It is a tautomer of a 5-guanidino-2-oxopentanoic acid zwitterion.

Names & identifiers

Preferred name
alpha-keto-delta-Guanidinovaleric acid
IUPAC
5-(diaminomethylideneamino)-2-oxopentanoic acid
English name
5-(diaminomethylideneamino)-2-oxo-pentanoic acid
Molecular formula
C6H11N3O3
Molecular weight
173.17

Names & synonyms

3715-10-45-carbamimidamido-2-oxopentanoic acidalpha-Keto-delta-guanidinovaleric acid2-Oxo-5-guanidinovaleric acidDTXSID001906325-((Aminoiminomethyl)amino)-2-oxopentanoic acidRefChem:555765DTXCID40113123847-966-72-oxoarginine5-guanidino-2-oxopentanoic aciddelta-Guanido-a-ketovaleric Acid
Show more names
-Guanido-α-ketovalericAcidAKA 2-OxoarginineArginine Impurity 33δ-Guanido-α-ketovaleric Acidδ-Guanido-α-ketovaleric Acidα-keto-δ-Guanidinovaleric acid
2-Oxo-5-guanidinopentanoate5-(diaminomethylideneamino)-2-oxopentanoic acid5-Guanidino-2-oxo-pentanoate5-[(diaminomethylidene)amino]-2-oxopentanoic acid2-Oxo-5-guanidino-pentanoate5-(DIAMINOMETHYLIDENEAMINO)-2-OXO-PENTANOIC ACIDdelta-Guanido-alpha-ketovaleric acid5-Guanidino-2-oxovaleric acid

Database identifiers

CAS
3715-10-4

Properties

Computed structural properties

XLogP
-1.6
Topological polar surface area
119 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
4
Rotatable bonds
5
Heavy atoms
12
Formal charge
0
Complexity
208

Experimental & physicochemical properties

Physical DescriptionSolid

Physicochemical properties

Melting point
350 °C · >350 °C
Boiling point
331.8 · 331.8±44.0 °C(Predicted)
Density
1.45 · 1.45±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C Freezer, Under inert atmosphere
solubility
DMSO (Slightly), Methanol (Very Slightly, Heated), Water (Slightly)
form
Solid
pka
2.54 · 2.54±0.54(Predicted)
color
White to Off-White
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
335 · H335-H319-H315
Precautionary statements
264 · P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Toxicology

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 item

Uremic toxins such as alpha-keto-delta-guanidinoacetic acid are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Chemistry & industry

Pharmacology

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
Cellular LocationsExtracellular
Metabolite PathwaysD-Arginine and D-Ornithine Metabolism

Uses & manufacturing

UsesNaturally produced by the body (endogenous).

Applications

Usesδ-Guanido-α-ketovaleric Acid is a useful flavouring ingredient and a component of Cheddar cheese flavour.

Suppliers13 total

艾吉析科技(上海)有限公司17717235263 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
南京世洲生物科技有限公司025-025-85560043 17301488900 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
558
DTXSID
DTXSID00190632
ChEBI
CHEBI:28116
EC Number
847-966-7
Nikkaji
J616.728D
Signs and Symptoms · 1 item

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H335-H319-H315
Precautionary statements
P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
Standardpharm Co. Ltd.86-714-3992388 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
上海贝万塔生物科技有限公司021-67187366 19901745723 · [email protected]
南京世洲生物科技有限公司18351873721 · [email protected]
广州优南科技有限公司020-82000279 18988941452 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]

Additional notes

DefinitionChEBI: A 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group.